Publications
Detailed Information
A hospital-based case-control study of identifying ovarian cancer using symptom index
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Mi-Kyung | - |
dc.contributor.author | Kim, Kidong | - |
dc.contributor.author | Kim, Sun Min | - |
dc.contributor.author | Kim, Jae Weon | - |
dc.contributor.author | Song, Yong-Sang | - |
dc.contributor.author | Kang, Soon-Beom | - |
dc.contributor.author | Park, Noh-Hyun | - |
dc.date.accessioned | 2012-06-04T01:29:18Z | - |
dc.date.available | 2012-06-04T01:29:18Z | - |
dc.date.issued | 2009-12 | - |
dc.identifier.citation | JOURNAL OF GYNECOLOGIC ONCOLOGY; Vol.20 4; 238-242 | ko_KR |
dc.identifier.issn | 2005-0380 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76747 | - |
dc.description.abstract | Objective: Recently, a symptom index for identification of ovarian cancer, based on specific symptoms along with their frequency and duration, was proposed. The current study aimed at validation of this index in Korean population. Methods: A case-control study of 116 women with epithelial ovarian cancer and 209 control women was conducted using questionnaires on eight symptoms. These included pelvic/abdominal pain, urinary urgency/frequency, increased abdominal size/bloating, difficulty eating/feeling full. The symptom index was considered positive if any of the 8 symptoms present for < 1 year that occurred > 12 times per month. The symptoms were compared between ovarian cancer group and control group using chi-square test. Logistic regression analysis was used to determine whether the index predicted cancer. Sensitivity and specificity of the symptom index were also determined. Results: The symptom index was positive in 65.5% of women with ovarian cancer, in 31.1% of women with benign cysts, and in 6.7% of women on routine screening (ps < 0.001). Significantly higher proportion of ovarian cancer patients were positive for each symptom as compared with control group (ps < 0.001). Results from the logistic regression indicated that the symptom index independently predicted cancer (p < 0.001; OR, 10.51; 95% Cl, 6.14 to 17.98). Overall, the sensitivity and specificity of the symptom index were 65.5% and 84.7%, respectively. Analyses of sensitivity by stage showed that the index was positive in 44.8% of patients with stage I/II disease and in 72.9% of patients with stage III/IV disease. Conclusion: The current study supported previous studies suggesting that specific symptoms were useful in identifying women with ovarian cancer. | ko_KR |
dc.description.sponsorship | This study was supported by a grant from the National R&D Program for
Cancer Control, Ministry for Health, Welfare and Family affairs, Republic of Korea (0920010). | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | KOREAN SOC GYNECOLOGY ONCOLOGY & COLPOSCOPY | ko_KR |
dc.subject | Ovarian cancer | ko_KR |
dc.subject | Symptoms | ko_KR |
dc.subject | Early diagnosis | ko_KR |
dc.subject | Case-control study | ko_KR |
dc.title | A hospital-based case-control study of identifying ovarian cancer using symptom index | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 김미경 | - |
dc.contributor.AlternativeAuthor | 김기동 | - |
dc.contributor.AlternativeAuthor | 김선민 | - |
dc.contributor.AlternativeAuthor | 김재원 | - |
dc.contributor.AlternativeAuthor | 박노현 | - |
dc.contributor.AlternativeAuthor | 송용상 | - |
dc.contributor.AlternativeAuthor | 강순범 | - |
dc.identifier.doi | 10.3802/jgo.2009.20.4.238 | - |
dc.citation.journaltitle | JOURNAL OF GYNECOLOGIC ONCOLOGY | - |
dc.description.citedreference | Hamilton W, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2998 | - |
dc.description.citedreference | Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9 | - |
dc.description.citedreference | Andersen MR, 2008, CANCER-AM CANCER SOC, V113, P484, DOI 10.1002/cncr23577 | - |
dc.description.citedreference | Goff BA, 2007, CANCER, V109, P221, DOI 10.1002/cncr.22371 | - |
dc.description.citedreference | 2007, LANCET, V369, P2051 | - |
dc.description.citedreference | Olivier RI, 2006, GYNECOL ONCOL, V100, P20, DOI 10.1016/j.ygyno.2005.08.038 | - |
dc.description.citedreference | Friedman GD, 2005, FAM PRACT, V22, P548, DOI 10.1093/fampra/cmi044 | - |
dc.description.citedreference | Lataifeh I, 2005, AUST NZ J OBSTET GYN, V45, P211 | - |
dc.description.citedreference | Yawn BP, 2004, MAYO CLIN PROC, V79, P1277 | - |
dc.description.citedreference | Goff BA, 2004, JAMA-J AM MED ASSOC, V291, P2705 | - |
dc.description.citedreference | Webb PM, 2004, GYNECOL ONCOL, V92, P232, DOI 10.1016/j.ygyno.2003.09.005 | - |
dc.description.citedreference | Vine MF, 2003, GYNECOL ONCOL, V90, P75, DOI 10.1016/S0090-8258(03)00175-6 | - |
dc.description.citedreference | PARKIN DM, 2002, CA CANC J CLIN, V55, P74 | - |
dc.description.citedreference | Olson SH, 2001, OBSTET GYNECOL, V98, P212 | - |
dc.description.citedreference | Goff BA, 2000, CANCER, V89, P2068 | - |
dc.description.citedreference | Eltabbakh GH, 1999, GYNECOL ONCOL, V75, P476 | - |
dc.description.citedreference | Jacobs IJ, 1999, LANCET, V353, P1207 | - |
dc.description.citedreference | JACOBS I, 1993, BRIT MED J, V306, P1030 | - |
dc.description.citedreference | SMITH EM, 1985, CANCER, V56, P2727 | - |
dc.description.tc | 8 | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.